These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Mechanisms of Mitochondrial Malfunction in Alzheimer's Disease: New Therapeutic Hope. Nabi SU; Khan A; Siddiqui EM; Rehman MU; Alshahrani S; Arafah A; Mehan S; Alsaffar RM; Alexiou A; Shen B Oxid Med Cell Longev; 2022; 2022():4759963. PubMed ID: 35607703 [TBL] [Abstract][Full Text] [Related]
6. AP39, a Mitochondria-Targeted Hydrogen Sulfide Donor, Supports Cellular Bioenergetics and Protects against Alzheimer's Disease by Preserving Mitochondrial Function in APP/PS1 Mice and Neurons. Zhao FL; Fang F; Qiao PF; Yan N; Gao D; Yan Y Oxid Med Cell Longev; 2016; 2016():8360738. PubMed ID: 27057285 [TBL] [Abstract][Full Text] [Related]
7. The role of mitophagy in the regulation of mitochondrial energetic status in neurons. Han S; Zhang M; Jeong YY; Margolis DJ; Cai Q Autophagy; 2021 Dec; 17(12):4182-4201. PubMed ID: 33757395 [TBL] [Abstract][Full Text] [Related]
8. Mitochondria dysfunction in the pathogenesis of Alzheimer's disease: recent advances. Wang W; Zhao F; Ma X; Perry G; Zhu X Mol Neurodegener; 2020 May; 15(1):30. PubMed ID: 32471464 [TBL] [Abstract][Full Text] [Related]
10. Mitochondria and vascular lesions as a central target for the development of Alzheimer's disease and Alzheimer disease-like pathology in transgenic mice. Aliev G; Seyidova D; Lamb BT; Obrenovich ME; Siedlak SL; Vinters HV; Friedland RP; LaManna JC; Smith MA; Perry G Neurol Res; 2003 Sep; 25(6):665-74. PubMed ID: 14503022 [TBL] [Abstract][Full Text] [Related]
11. Mitochondrial Dysfunction and Oxidative Stress in Alzheimer's Disease. Misrani A; Tabassum S; Yang L Front Aging Neurosci; 2021; 13():617588. PubMed ID: 33679375 [TBL] [Abstract][Full Text] [Related]
12. Mitochondria in Aging and Alzheimer's Disease: Focus on Mitophagy. Pradeepkiran JA; Baig J; Selman A; Reddy PH Neuroscientist; 2023 Jan; ():10738584221139761. PubMed ID: 36597577 [TBL] [Abstract][Full Text] [Related]
13. Study of mitophagy and ATP-related metabolomics based on β-amyloid levels in Alzheimer's disease. Xiong X; Li S; Han TL; Zhou F; Zhang X; Tian M; Tang L; Li Y Exp Cell Res; 2020 Nov; 396(1):112266. PubMed ID: 32905804 [TBL] [Abstract][Full Text] [Related]
14. Cholesterol alters mitophagy by impairing optineurin recruitment and lysosomal clearance in Alzheimer's disease. Roca-Agujetas V; Barbero-Camps E; de Dios C; Podlesniy P; Abadin X; Morales A; Marí M; Trullàs R; Colell A Mol Neurodegener; 2021 Mar; 16(1):15. PubMed ID: 33685483 [TBL] [Abstract][Full Text] [Related]
15. Impaired mitochondrial biogenesis, defective axonal transport of mitochondria, abnormal mitochondrial dynamics and synaptic degeneration in a mouse model of Alzheimer's disease. Calkins MJ; Manczak M; Mao P; Shirendeb U; Reddy PH Hum Mol Genet; 2011 Dec; 20(23):4515-29. PubMed ID: 21873260 [TBL] [Abstract][Full Text] [Related]
16. Abnormal mitochondrial dynamics and synaptic degeneration as early events in Alzheimer's disease: implications to mitochondria-targeted antioxidant therapeutics. Reddy PH; Tripathi R; Troung Q; Tirumala K; Reddy TP; Anekonda V; Shirendeb UP; Calkins MJ; Reddy AP; Mao P; Manczak M Biochim Biophys Acta; 2012 May; 1822(5):639-49. PubMed ID: 22037588 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of ERK-DLP1 signaling and mitochondrial division alleviates mitochondrial dysfunction in Alzheimer's disease cybrid cell. Gan X; Huang S; Wu L; Wang Y; Hu G; Li G; Zhang H; Yu H; Swerdlow RH; Chen JX; Yan SS Biochim Biophys Acta; 2014 Feb; 1842(2):220-31. PubMed ID: 24252614 [TBL] [Abstract][Full Text] [Related]
18. Molecular Basis of Alzheimer's Disease: Focus on Mitochondria. Oliver DMA; Reddy PH J Alzheimers Dis; 2019; 72(s1):S95-S116. PubMed ID: 30932888 [TBL] [Abstract][Full Text] [Related]